UnitedHealthcare
Ocrevus (ocrelizumab)
Drugs for the Nervous System : Drugs for Multiple Sclerosis
  • Prior Authorization: Multiple Sclerosis (MS):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Step Therapy: Multiple Sclerosis (MS):
    ST Single Brand

  • Multiple Sclerosis (MS):
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: <= 12 month(s)
    Patients Cardiac Medical History Required: No
    Concomitant use of other MS medication: No
    Supporting Documentation Requirements: 2 of Chart Notes;Lab Tests